Document center

IRRADIUM Magazine - The annual magazine of the MCAA (2026)

Published on | 3 months ago

Programmes MSCA

Table of contents

Letter from the Chair

Page 4 The fruit of accumulated preliminary work

Editorial

Page 8 - MSCA at 30: From individual to collective progress

30th Anniversary of the MSCA

Page 10 - MSCA postdoctoral fellowships: Learning to design impact, not just research

Page 13 - From Twente to Harvard and back: My MSCA journey

Page 16 - 3+1 reasons to do an MSCA doctorate Notes on Policy

Notes on Policy

Page 18 - From advocacy to impact: A milestone at the inaugural MCAA Policy Forum

Page 21 - The 2025 MSCA Impact Report: Purpose and findings

Page 24 - Turning research into competitiveness: Time for a European Research Area Act

News from the MCAA

Page 27 - 2025 in focus: Expanding research cultures, changing scientific practice, and global connectivity

Advertorial

Page 35 - Oportunius: A gateway to research excellence in Galicia

Page 38 - Accessibility statement

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.